Noah J. PhillipsOvjeren akaunt

@FTCPhillips

Official account of Commissioner Noah J. Phillips. Retweets, Follows, & Likes ≠ Endorsements

Washington, DC
ftc.gov
Vrijeme pridruživanja: svibanj 2018.
16 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @FTCPhillips

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FTCPhillips

  1. proslijedio/la je Tweet
    prije 14 sati

    FDA and release joint statement outlining new efforts to address false or misleading promotion about biosimilars, deter anti-competitive business practices and support a competitive market for biological products: .

    1 reply 11 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  2. prije 17 sati

    By bringing the disruptive Harry’s under Edgewell’s control, the complaint alleges, the proposed acquisition would eliminate important and growing competition among suppliers of wet shave razors, and would inflict significant harm on consumers of razors across the United States.

    FTC files suit to block Edgewell Personal Care Company’s acquisition of Harry’s, Inc. Merger would allegedly eliminate competition that drove down razor prices, spurred innovation:
    2 korisnika označavaju da im se sviđa
    Poništi
  3. 31. sij

    Those interested in my prepared speech can read it here

    4 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  4. 30. sij

    Later, I had the pleasure of giving a lunchtime speech on the idea of converging of antitrust and privacy law and answering questions there. Thanks !

    1 reply 1 proslijeđeni tweet 14 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  5. proslijedio/la je Tweet
    30. sij

    Thanks to for coming to my class today - nice when an alum comes back to share the wisdom with current students!

    Enjoyed guest lecturing today on the Facebook privacy settlement and answering insightful questions from students. Thanks, Professor
    Prikaži ovu nit
    3 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  6. 30. sij

    Enjoyed guest lecturing today on the Facebook privacy settlement and answering insightful questions from students. Thanks, Professor

    6 proslijeđenih tweetova 22 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  7. 28. sij

    This case continues the FTC's exceptional work to protect competition and consumers in healthcare markets. (6/6)

    1 reply 2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  8. 28. sij

    We allege that Vyera's restrictive distribution agreements, exclusive manufacturing agreements, and data blocking agreements sought to and did impede generic entry, preventing market forcing from working to bring the price down. (5/6)

    1 reply
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  9. 28. sij

    Daraprim is the gold-standard treatment for toxoplasmosis, a rare parasitic infection that, if untreated, can prove fatal. (4/6)

    1 reply
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  10. 28. sij

    The complaint alleges that the defendants undertook a scheme to maintain its monopoly and extremely high prices (raised over 4,000%) for Daraprim. (3/6)

    1 reply
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  11. 28. sij

    Yesterday, the FTC and the NY AG sued Vyera Pharmaceuticals and two of its executives, Martin Shkreli and Kevin Mulleady; (2/6)

    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  12. 28. sij

    Getting to this a little late, but for those who missed this important news (1/6)

    FTC and charge Vyera Pharmaceuticals, Martin Shkreli, and other defendants with anticompetitive scheme to protect a list-price increase of more than 4,000% for life-saving drug Daraprim:
    Prikaži ovu nit
    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  13. 27. sij

    Looking forward to joining students, faculty and others at and 's Rock Center to discuss

    Tweet je nedostupan.
    2 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    23. sij

    Next Thursday, 1/30, is hosting FTC Commissioner for a lunchtime talk. Please join us if you are in the area (RSVP here):

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  15. 16. sij

    . continues its enforcement of the Privacy Shield program, finalizing settlements with 5 companies over allegations they misrepresented participation with the framework that facilitates consumer data transfers from the EU and Switzerland to the US.

    6 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  16. 13. sij

    Important policy discussions at today’s ’s event “Will Kids’ Privacy Crackdown Break the Internet?” regarding and its impact on the digital economy. Enjoyed fireside chat with and appreciated the opportunity to listen to the views of stakeholders.

    12 replies 17 proslijeđenih tweetova 117 korisnika označava da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    2. sij

    Statement of Gail Levine, Deputy Director of FTC Bureau of Competition, regarding the announcement that Illumina Inc. has abandoned its proposed acquisition of Pacific Biosciences of California:

    13 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  18. 18. pro 2019.

    The alleged harms to competition include reduced incentives to innovate and develop new products, demonstrating the FTC’s continuing commitment to considering innovation effects in antitrust analysis. (4/4)

    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  19. 18. pro 2019.

    The administrative complaint alleges that the proposed acquisition is illegal because it unlawfully maintains Illumina’s monopoly in the next-gen DNA sequencing market and also because it may substantially lessen competition in that market. (3/4)

    1 reply 3 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  20. 18. pro 2019.

    PacBio has achieved significant technological advancements in recent years, which have made it a closer competitor to Illumina for certain use cases and applications, and it is poised to take more volume from Illumina in the future. (2/4)

    1 reply 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi

@FTCPhillips još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·